Recent studies have demonstrated aberrant expression of cyclin B1 in several malignant cancers, including breast cancer [9], esophageal squamous cell carcinoma [10], nonsmall cell carcinoma [11], gastric cancer [12], and hepatocellular carcinoma [13]. This evidence concerns the gene CCNB1 and breast carcinoma.